Background. Mid-dermal elastolysis (MDE) is a rare skin condition, characterized by selective loss of elastic fibres in the mid dermis. The pathogenesis of MDE is still unclear. Aim. To investigate expression of lysyl oxidase-like 2 (LOXL2) in a reasonable sample of patients with MDE and to search for mutations in LOXL2. Methods. We investigated archived lesional tissue of 13 patients with MDE and skin tissue samples of 10 sex-and age-matched healthy controls (HCs). Gene and protein expression of LOXL2 was investigated using real-time reverse-transcription PCR and immunohistochemistry. Mutation analysis was performed using the Sanger method. Results. We observed decreased LOXL2 mRNA expression in lesional skin of patients with MDE (0.48 AE 0.16) compared with healthy skin of the same patients (1.5 AE 0.51) and normal skin of HCs (1.9 AE 0.13). Compared with healthy patient skin (epidermis 2.38 AE 1.6, dermis 1.2 AE 1), LOXL2 protein expression in lesional patient skin (epidermis 1.1 AE 0.7, dermis 0.3 AE 0.45) was significantly decreased (P < 0.04 and P = 0.02, respectively). Mutation analysis of the entire LOXL2 gene could be performed for five patients, all of whom were found to have at least one mutation in the LOXL2 gene. Three of these had a mutation in the promoter region (c.967 G>C, c.1022 C>T, and c.1025 G>A, respectively), and one of them also had a mutation in the splice region of intron 11/exon 12 (IVS11-1 G>A). Of the remaining two patients, one had a mutation in exon 3 (T1391), and the other had a mutation in exon 11 (C663Y). Conclusions. Our present data suggest that decreased elastin renewal due to LOXL2 mutations and consecutive reduced LOXL2 expression contribute to the pathogenesis of MDE.
Introduction
Mid-dermal elastolysis (MDE) is a rare skin condition, characterized by selective loss of elastic fibres in the mid dermis, clinically resulting in well-circumscribed fine wrinkles and/or discrete perifollicular papular protusions, which are usually symmetrically arranged on the trunk and proximal aspects of the limbs. The pathogenesis of MDE is still obscure. Elastase/antielastase alterations and an imbalance between degradation and elastin renewal seem to play an important role in MDE. 1, 2 Fibulins are involved in various aspects of elastic fibre development and renewal. 3 We have recently demonstrated that expression of fibulin-4 and fibulin-5 is significantly reduced in patients with MDE compared with healthy controls (HCs). 4 The lysyl oxidase (LOX) family is a group of amine oxidases responsible for the formation of collagen and elastin fibrils in the extracellular matrix. In addition to LOX, four LOXlike proteins (LOXL1-4) produced by the same gene family have been identified, which play a major role in biosynthesis and renewal of the elastic tissue. 5, 6 We recently published a case report showing that expression of LOXL2 is reduced in MDE. 7 In the present study, we aimed to investigate LOXL2 expression in a larger sample of patients with MDE and to search for mutations in the gene LOXL2.
Methods
The study was approved by the ethics review board of the Ruhr-University Bochum (no. 4222-12) and conducted according to the principles of the Declaration of Helsinki. All participants provided written informed consent.
Participants
We investigated archived lesional formalin-fixed, paraffinwax-embedded (FFPE) and the housekeeping gene RPL-38 were designed using computer software (Primer Express 3.0; Applied Biosystems) and produced by a custom oligonucleotide synthesis service (TIB Molbiol, Berlin, Germany). PCR amplifications were performed in a total volume of 25 lL, containing 5 lL cDNA sample, 5 lmol/L of each primer and 12.5 lL master mix (Power SYBR â Green PCR Master Mix). PCR was performed with the following parameters: 2 min at 50°C and an initial 10 min denaturation at 95°C, followed by 40 cycles of denaturing for 15 s at 60°C, and annealing and elongation for 1 min at 60°C. Quantitative mRNA levels were determined using the median log transformation of the gene expression. Relative mRNA expression levels were calculated using the comparative ÀDD C t method as previously reported by Livak and Schmittgen. 8 Quantities of all targets in the test samples were normalized to the corresponding RPL38 RNA transcript in the skin samples.
LOXL2 immunohistochemistry
For immunohistology of LOXL2, we used rabbit polyclonal LOXL2 (1:500 dilution; Abcam plc, Cambridge, UK) at pH6. An antigen retrieval step was performed using citrate buffer and a steamer for 30 min. 
Statistical analysis
Data analysis was performed using the statistical package MedCalc Software (v15.2; Mariakerke, Belgium). Distribution of data was assessed by means of the D'Agostino-Pearson test. Based on distribution, data were expressed as mean AE SD. Because of heterogenous variances, however, we used a nonparametric test (Mann-Whitney) for evaluation of the immunohistology data. Differences were considered significant when P < 0.05.
Results
We observed decreased LOXL2 mRNA expression (0.48 AE 0.16) in lesional skin of patients with MDE compared with their healthy skin (1.5 AE 0.51) and with the normal skin of HCs (1.9 AE 0.13). Compared with healthy patient skin (epidermis: 2.38 AE 1.6, dermis: 1.2 AE 1), LOXL2 protein expression in lesional skin (epidermis 1.1 AE 0.7, dermis 0.3 AE 0.45) of patients with MDE was significantly decreased (P < 0.04 and P = 0.02, respectively; Fig. 1 ). Owing to the limited amount and poor quality of the FFPE tissue we could perform mutation analysis of the entire LOXL2 gene for only five patients, all of whom were found to have at least one mutation in the LOXL2 gene (Fig. 2) . Three of these patients had a mutation in the promoter region (c.967 G>C, c.1022 C>T, and c.1025 G>A, respectively), and one of them also had a mutation in the splice region of intron 11/exon 12 (IVS11-1 G>A). Of the remaining two patients, one had a mutation in exon 3 (T1391), and the other had a mutation in exon 11 (C663Y).
Discussion
It has been shown that the matrix metalloproteinases (MMP)-1 and-9 are overexpressed in MDE, indicating that increased elastolytic activity by MMPs appears to be an important pathogenic factor in MDE. 9 LOXL enzymes have been shown to maintain homeostasis of elastic fibres and to be associated with human skin elastogenesis, in particular during the first decades of life. 5, 6, 10, 11 In the present study, we found that LOXL2 mRNA and protein expression was reduced in lesional skin of patients with MDE when compared with HCs. The LOXL2 mutations found in the present study may explain the reduction in gene and protein expression observed.
In particular, the mutations observed in the promoter region of LOXL2 may affect binding of transcription factors, leading to diminished gene expression. 12 The LOXL2 promotor region probably includes numerous docking sites for transcription factors. 13 Mutations in the promotor region may prevent binding of these transcription factors and thus significantly affect gene expression.
The mutation T139I (exon 3) is located in the region of the scavenger-receptor cysteine-rich domain 1 (SRCR1). Scavenger receptors are frequently found on the cell surface and adhesion molecules, and represent an important part of the innate immune system. The mutation C663Y in exon 11 affects the highly conserved region of the cytokine-receptor-like domain of all LOX family members.
Another interesting finding of our study is the LOXL2 mutation within the region of the splice site of intron 11 and exon 12. With such a mutation at this site, the sequence of the intron-exon transitions is so severely altered that correct connection of exons or removal of introns from the primary mRNA transcript is prevented. 12, 14 In most cases, the aforementioned mutation means that either whole exons are skipped or wrong splice sites are used.
LOX/LOXL also play a role in the pathogenesis of other elastolytic disorders such as cutis laxa. 15, 16 Debret et al. 15 reported that LOXL1 gene regulation was altered by epigenetic mechanisms such as DNA hypermethylation. Hence, apart from LOX/LOX mutations, Figure 2 Lysyl oxidase-like 2 (LOXL2) gene structure and the various mutations detected in lesional skin of patients (n = 5) with mid-dermal elastolysis.
ª 2018 British Association of Dermatologists epigenetic alterations of these genes may also contribute to the pathogenesis of elastolytic conditions. In accordance with this, we recently observed LOXL2 promoter hypermethylation in MDE lesions. 17 A limitation of the present study is the absence of functional studies confirming whether the LOXL2 mutations detected can really explain the decreased LOXL2 expression in MDE lesions.
Conclusion
Our data suggest that decreased elastin renewal due to LOXL2 mutations and consecutive reduced LOXL2 expression contributes to the pathogenesis of MDE.
What's already known about this topic?
• MDE is a rare skin disease causing loss of the elastic tissue in the mid-dermis, resulting in skin wrinkling.
• Recent data suggest that elastase/antielastase alterations and an imbalance between degradation and elastin renewal seem to play an important role in MDE.
What does this study add?
• Our data suggest that LOXL2 gene mutations result in decreased gene and protein expression and thus probably play a role in the pathogenesis of mid-dermal elastolysis.
